Skip to main content

Healthcare Integrated Technologies Inc

For the period ended Apr 30, 2024. Filed Jun 20, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Apr 30, 2024 · Filed Jun 20, 2024

SSGCStored price and day change unavailable

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Interim Consolidated Statements of Cash Flows (Unaudited)

INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS

For the Nine Months Ended April 30,
2024 · 2023
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss$(598,881)$(1,107,521)
Adjustments to reconcile loss to net cash used in operating activities:
Amortization167,09113,475
Stock-based compensation104,196243,005
Shares issued for services-15,000
Shares issued for note amendment fees-100,000
Amortization of debt discount-194,394
Change in fair value of derivative liability-11,617
Changes in operating assets and liabilities:
Accounts receivable, net(14,000)-
Prepaid expenses and other current assets1,0702,561
Accounts payable and accrued expenses28,47177,527
Accounts payable and accrued expenses, related party(70,381)242,550
Payroll related liabilities184,082129,827
NET CASH USED BY OPERATING ACTIVITIES(198,352)(77,565)
CASH FLOWS FROM INVESTING ACTIVITIES
Cash paid for intangible assets-(22,388)
NET CASH USED BY INVESTING ACTIVITIES-(22,388)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from issuance of common stock325,000300,000
Repayment of short-term debt-(150,000)
Proceeds from related party loans72,03094,401
Payments of amounts owed to related parties(199,059)(63,161)
NET CASH PROVIDED BY FINANCING ACTIVITIES197,971181,240
Net change in cash and cash equivalents(381)81,287
Cash and cash equivalents, beginning of period4111,051
Cash and cash equivalents, end of period$30$82,338
SUPPLEMENTAL CASH FLOW INFORMATION
Cash paid for interest$-$30,000
SIGNIFICANT NON-CASH INVESTING AND FINANCING ACTIVITIES
Capital expenditures included in payroll related liabilities$82,998
Capital expenditures from stock-based compensation$57,991
Shares issued for payment of convertible debt$150,000
Shares issued for payment of accrued expenses$37,586
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.